InQpharm’s leading natural appetite management product, Appecal™, is approved for general weight management, prevention and treatment of obesity. Launched in two markets in 2009, it is now selling successfully in over 18 European markets, with the top three selling countries being France, Spain and Germany.
Certified as a Class IIa medical device, Appecal™ helps to promote a pleasant feeling of satiety to control appetite and hunger pangs. It is specially formulated with a proprietary ingredient, Redusure™, a specialised fibre complex derived from the tuberous roots of the plant Amorphophallus konjac which is water-soluble, and can swell to up to 50 times its original size!
Appecal™ is certified and manufactured according to the stringent EN ISO 13485 for medical devices. The high-swelling, viscosity and bulk-forming capabilities among natural fibres are the scientific basis for Appecal™'s medical device licence (MDD/93/42/EEC) for general weight management, prevention and treatment of obesity. This offers new and unique business opportunities with claims approved EU-wide.
Appecal™ is part of the BMIsmart™ range of weight management products tailored to help individuals achieve their own desired weight with a healthy Body Mass Index (BMI). Read about our other BMIsmart™ products, Liposinol™, Glucosanol™ and Zenoctil™.